Bristol-Myers Squibb
BMY
BMY
1,812 hedge funds and large institutions have $61.5B invested in Bristol-Myers Squibb in 2019 Q1 according to their latest regulatory filings, with 196 funds opening new positions, 722 increasing their positions, 668 reducing their positions, and 129 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
2% more funds holding in top 10
Funds holding in top 10: 41 → 42 (+1)
8% more repeat investments, than reductions
Existing positions increased: 722 | Existing positions reduced: 668
2% less capital invested
Capital invested by funds: $62.7B → $61.5B (-$1.2B)
Holders
1,812
Holding in Top 10
42
Calls
$3.19B
Puts
$2.69B
Top Buyers
| 1 | +$1.54B | |
| 2 | +$300M | |
| 3 | +$269M | |
| 4 |
Two Sigma Advisers
New York
|
+$263M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$247M |
Top Sellers
| 1 | -$486M | |
| 2 | -$407M | |
| 3 | -$396M | |
| 4 |
Harris Associates
Chicago,
Illinois
|
-$318M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$241M |